[1] Zhang S,Batur P.Human papillomavirus in 2019:an update on cervical cancer prevention and screening guidelines[J].Cleve Clin J Med,2019,86(3):173-178. [2] Sawaya GF,Smith-Mccune K,Kuppermann M.Cervical cancer screening:more choices in 2019[J].JAMA,2019,321(20):2018-2019. [3] Zhao X,Cui Y,Jiang S,et al.Comparative study of HR HPV E6/E7 mRNA and HR-HPV DNA in cervical cancer screening[J].Natl Med J China,2014,94(43):3432-3435. [4] Monsonego J.EUROGIN 2010:roadmap on cervical cancer prevention[J].Gynecol Obstet Fertil,2011,39(7-8):462-467. [5] Arbyn M,Weiderpass E,Bruni L,et al.Estimates of incidence and mortality of cervical cancer in 2018:a worldwide analysis[J].Lancet Glob Health,2020,8(2):e191-e203. [6] 徐维,曾孟兰,杨黎明.HPV感染与年轻宫颈癌的关系[J].实用预防医学,2009,16(4):1151-1152. [7] 赵宇倩,赵方辉,胡尚英,等.中国女性人群宫颈人乳头瘤病毒感染及型别分布的多中心横断面研究[J].中华流行病学杂志,2015,36(12):1351-1356. [8] Fleming K,Simmons VN,Christy SM,et al.Educating hispanic women about cervical cancer prevention:feasibility of a promotora-led charla intervention in a farmworker community[J].Ethn Dis,2018,28(3):169-176. [9] 张驰东,高燕,缪应新,等.上海地区老年女性人乳头状瘤病毒感染型别分布特征[J].老年医学与保健,2018,24(4):397-400. [10] Zhao P,Liu S,Zhong Z,et al.Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China[J].BMC Infect Dis,2018,18(1):204. [11] Zhang C,Cheng W,Liu Q,et al.Distribution of human papillomavirus infection:a population-based study of cervical samples from Jiangsu Province[J].Virol J,2019,16(1):67. [12] Xiang F,Guan Q,Liu X,et al.Distribution characteristics of different human papillomavirus genotypes in women in Wuhan,China[J].J Clin Lab Anal,2018,32(8):e22581. [13] Lu JF,Shen GR,Li Q,et al.Genotype distribution characteristics of multiple human papillomavirus in women from the Taihu River Basin,on the coast of eastern China[J].BMC Infect Dis,2017,17(1):226. [14] Tang Y,Zheng L,Yang S,et al.Epidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China:a cross-sectional five years study in non-vaccinated women[J].Virol J,2017,14(1):84. [15] 孙瑞,郝华,汤传梅,等.宫颈上皮内瘤变及宫颈癌患者人乳头瘤病毒基因型及病毒载量的变化研究[J].实用预防医学,2017,24(8):996-999. [16] 黄丽丽,赵兰静,吴茵.等.3 565例女性体检人群人乳头瘤病毒感染情况及型别分布[J].实用预防医学,2020,27(5):609-611. [17] Jiang L,Tian X,Peng D,et al.HPV prevalence and genotype distribution among women in Shandong Province,China:analysis of 94,489 HPV genotyping results from Shandong's largest independent pathology laboratory[J].PLoS One,2019,14(1):e210311. [18] Wang J,Tang D,Wang K,et al.HPV genotype prevalence and distribution during 2009-2018 in Xinjiang,China:baseline surveys prior to mass HPV vaccination[J].BMC Womens Health,2019,19(1):90. [19] Zhao JW,Xu JJ,Yan M,et al.Prevalence and genotype distribution of human papillomavirus:implications for cancer screening and vaccination in Henan Province,China[J].Rev Soc Bras Med Trop,2016,49(2):237-240. [20] Gupta SM,Mania-Pramanik J.Molecular mechanisms in progression of HPV-associated cervical carcinogenesis[J].J Biomed Sci,2019,26(1):28. [21] 戈文舜,钱洁芳,任丽芳,等.不同年龄HR-HPV病检结果在宫颈癌筛查中的价值[J].中国妇幼健康研究,2019,30(11):1368-1373. [22] 刘芳林,路影,李飞飞,等.宫颈分泌物检测HPV基因型对老年宫颈癌癌前病变的筛查效果[J].中国老年学杂志,2020,40(23):4956-4958. [23] 吴颖,曹芬芳,刘太林,等.湖南地区7 076例女性HPV感染情况及分型分析[J].实用预防医学,2019,26(4):474-476.